MDM2 Overexpression Deregulates the Transcriptional Control of RB/E2F Leading to DNA Methyltransferase 3A Overexpression in Lung Cancer

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Clinical Cancer Research

• Publication date

  2012-06-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-11-2617PMID 22733537
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• DNMT3A mutations in acute myeloid leukemia: stability during disease evolution and clinical implications.

  2012cited by this paper
• Recent advances in the therapeutic perspectives of Nutlin-3.

  2011cited by this paper
• Incidence and prognostic influence of DNMT3A mutations in acute myeloid leukemia.

  2011cited by this paper
• DNMT3A mutations in acute myeloid leukemia

  2011cited by this paper
• Recurrent DNMT3A Mutations in Patients with Myelodysplastic Syndromes

  2011cited by this paper
• Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia

  2011cited by this paper
• Array-based genomic resequencing of human leukemia

  2010cited by this paper
• The tobacco-specific carcinogen NNK induces DNA methyltransferase 1 accumulation and tumor suppressor gene hypermethylation in mice and lung cancer patients.

  2010cited by this paper
• DNMT3A mutations in acute myeloid leukemia.

  2010cited by this paper
• Distinct Epigenetic Domains Separated by a CTCF Bound Insulator between the Tandem Genes, BLU and RASSF1A

  2010cited by this paper
• SLIT2 attenuation during lung cancer progression deregulates beta-catenin and E-cadherin and associates with poor prognosis.

  2010cited by this paper
• MicroRNA-143 targets DNA methyltransferases 3A in colorectal cancer

  2009cited by this paper
• Nutlin-3 Affects Expression and Function of Retinoblastoma Protein

  2009cited by this paper
• MicroRNA-29b induces global DNA hypomethylation and tumor suppressor gene reexpression in acute myeloid leukemia by targeting directly DNMT3A and 3B and indirectly DNMT1.

  2009cited by this paper
• An essential role for DNA methyltransferase 3a in melanoma tumorigenesis.

  2009cited by this paper
• Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.

  2009cited by this paper
• Cellular mechanisms of tumour suppression by the retinoblastoma gene

  2008cited by this paper
• MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B

  2007influential reference
• Alteration of DNA methyltransferases contributes to 5'CpG methylation and poor prognosis in lung cancer.

  2007cited by this paper
• Human polyomavirus BKV transcriptionally activates DNA methyltransferase 1 through the pRb/E2F pathway

  2006cited by this paper
• [Cancer epigenetics].

  2006cited by this paper
• RB and cell cycle progression

  2006cited by this paper
• Cancer epigenetics.

  2005cited by this paper
• Enhanced Mdm2 activity inhibits pRB function via ubiquitin‐dependent degradation

  2005cited by this paper
• MDM2 promotes proteasome-dependent ubiquitin-independent degradation of retinoblastoma protein.

  2005cited by this paper
• Regulation of DNA methyltransferase 1 by the pRb/E2F1 pathway.

  2005cited by this paper
• Epidermal Growth Factor-induced Rapid Retinoblastoma Phosphorylation at Ser780 and Ser795 Is Mediated by ERK1/2 in Small Intestine Epithelial Cells*

  2005cited by this paper
• Wild-type p53 overexpression and its correlation with MDM2 and p14ARF alterations: an alternative pathway to non-small-cell lung cancer.

  2005cited by this paper
• Expression analysis of DNA methyltransferases 1, 3A, and 3B in sporadic breast carcinomas.

  2003cited by this paper
• Expression of DNA methyltransferases in multistep hepatocarcinogenesis.

  2003cited by this paper
• Transcription of mouse DNA methyltransferase 1 (Dnmt1) is regulated by both E2F-Rb-HDAC-dependent and -independent pathways.

  2003cited by this paper
• Antisense therapy targeting MDM2 oncogene in prostate cancer: Effects on proliferation, apoptosis, multiple gene expression, and chemotherapy

  2003cited by this paper
• DNA methyltransferase and demethylase in human prostate cancer

  2002cited by this paper
• Expression of DNA methyltransferases DNMT1,3A and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

  2001cited by this paper
• Dnmt3a binds deacetylases and is recruited by a sequence‐specific repressor to silence transcription

  2001cited by this paper
• Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia.

  2001cited by this paper
• DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development.

  1999cited by this paper
• The regulation of E2F by pRB-family proteins.

  1998cited by this paper
• Databases on transcriptional regulation: TRANSFAC, TRRD and COMPEL

  1998cited by this paper
• The MDM2 gene amplification database.

  1998cited by this paper
• Databases on transcriptional regulation : TRANSFAC , TRRD and COMPEL

  1997cited by this paper

• Modulating the p53-MDM2 pathway: the therapeutic potential of natural compounds in cancer treatment

  2024cites this paper
• State of the Art of Pharmacological Activators of p53 in Ocular Malignancies

  2023cites this paper
• Identification of MDM2 as a prognostic and immunotherapeutic biomarker in a comprehensive pan-cancer analysis: A promising target for breast cancer, bladder cancer and ovarian cancer immunotherapy.

  2023cites this paper
• MDM2 antagonist improves therapeutic activity of azacitidine in myelodysplastic syndromes and chronic myelomonocytic leukemia

  2022cites this paper
• CCRL2 affects the sensitivity of myelodysplastic syndrome and secondary acute myeloid leukemia cells to azacitidine

  2022influential citation
• Nutlin‐3 acts as a DNA methyltransferase inhibitor to sensitize esophageal cancer to chemoradiation

  2022cites this paper
• The intricate interplay between HIFs, ROS, and the ubiquitin system in the tumor hypoxic microenvironment.

  2022cites this paper
• Molecular Effects of Iodine-Biofortified Lettuce in Human Gastrointestinal Cancer Cells

  2022influential citation
• Activation of DNA methyltransferase 3a by Epstein-Barr nuclear antigen 1 in gastric carcinoma.

  2021cites this paper
• Comprehensive analysis of regulation of DNA methyltransferase isoforms in human breast tumors

  2021cites this paper
• Protein phosphatase 2A inactivation induces microsatellite instability, neoantigen production and immune response

  2021cites this paper
• De novo methyltransferases: Potential players in diseases and new directions for targeted therapy.

  2020cites this paper
• Retinoblastoma Tumor Suppressor Protein Roles in Epigenetic Regulation

  2020cites this paper
• Pharmaceutical Topical Delivery of Poorly Soluble Polyphenols: Potential Role in Prevention and Treatment of Melanoma

  2019cites this paper
• Regulation of cell cycle by MDM2 in prostate cancer cells through Aurora Kinase-B and p21WAF1/CIP1 mediated pathways.

  2019cites this paper
• Drug resistance to targeted therapeutic strategies in non-small cell lung cancer.

  2019cites this paper
• Epigenetic induction of CD1d expression primes lung cancer cells for killing by invariant natural killer T cells

  2018cites this paper
• Epigenetic Events in Lung Cancer: Chromatin Remodeling and DNA Methylation

  2018cites this paper
• E2F-1 targets miR-519d to regulate the expression of the ras homolog gene family member C

  2017cites this paper
• MDM2 is implicated in high‐glucose‐induced podocyte mitotic catastrophe via Notch1 signalling

  2017cites this paper
• Inhibition of DNA Methylation in the COL1A2 Promoter by Anacardic Acid Prevents UV-Induced Decrease of Type I Procollagen Expression.

  2017cites this paper
• DNA Methylation in Eukaryotes: Regulation and Function

  2017cites this paper
• A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo

  2017cites this paper
• Hypermethylation of miRNA-589 promoter leads to upregulation of HDAC5 which promotes malignancy in non-small cell lung cancer.

  2017cites this paper
• p53 is essential for DNA methylation homeostasis in naïve embryonic stem cells, and its loss promotes clonal heterogeneity

  2017cites this paper
• Effect of etoposide-induced alteration of the Mdm2-Rb signaling pathway on cellular senescence in A549 lung adenocarcinoma cells

  2017cites this paper
• The epigenetic effect of microRNA in BCR-ABL1‑positive microvesicles during the transformation of normal hematopoietic transplants.

  2017influential citation
• Dysfunction of the WT1-MEG3 signaling promotes AML leukemogenesis via p53-dependent and -independent pathways

  2017cites this paper
• Misregulation of DNA Methylation Regulators in Cancer

  2017cites this paper
• Epigenetic targeting of CD1d increases cytolytic activity of invariant natural killer T cells against non-small cell lung cancer cells

  2016cites this paper
• RING-, HECT-, and RBR-type E3 Ubiquitin Ligases: Involvement in Human Cancer.

  2016cites this paper
• PCDH8 is Frequently Inactivated by Promoter Hypermethylation in Liver Cancer: Diagnostic and Clinical Significance

  2016cites this paper
• Assessment of Promoter Hypermethylation and Expression Profile of P14ARF and MDM2 Genes in Patients With Pterygium

  2016cites this paper
• Epigenetic therapy in lung cancer and mesothelioma

  2015cites this paper
• O6‐methylguanine DNA methyltransferase repairs platinum‐DNA adducts following cisplatin treatment and predicts prognoses of nasopharyngeal carcinoma

  2015cites this paper
• Phytochemical screening, cytotoxicity and anticancer activity of Lobostemon fruticosus extracts on human lung cancer cell line

  2015cites this paper
• Targeting MDM4 as a Novel Therapeutic Approach for Hematologic Malignancies.

  2015cites this paper
• Association between SNP309 and del1518 Polymorphism in MDM2 Homologue and Esophageal Squamous Cell Carcinoma Risk in Chinese Population of Shandong Province.

  2015cites this paper
• A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.

  2015cites this paper
• Involvement of tumor suppressors PTEN and p53 in the formation of multiple subtypes of liposarcoma

  2015cites this paper
• Inhibition of intestinal tumor formation by deletion of the DNA methyltransferase 3a

  2014cites this paper
• Does KRAS mutational status predict chemoresistance in advanced non-small cell lung cancer (NSCLC)?

  2014cites this paper
• Targeting MDM2-p53 interaction for cancer therapy: are we there yet?

  2014cites this paper
• Stress-Induced Alternative Splice Forms of MDM2 and MDMX Modulate the p53-Pathway in Distinct Ways

  2014cites this paper
• Dysregulated transcriptional and post-translational control of DNA methyltransferases in cancer

  2014cites this paper
• Identification of somatic alterations in stage I lung adenocarcinomas by next‐generation sequencing

  2014cites this paper
• DNMT3B Overexpression by Deregulation of FOXO3a-Mediated Transcription Repression and MDM2 Overexpression in Lung Cancer

  2014cites this paper
• Deregulation of p53 and RB Transcriptional Control Leads to Overexpression of DNA Methyltransferases in Lung Cancer

  2014cites this paper
• The MDM2-p53 pathway revisited

  2013cites this paper
• Chemical biology approaches for the identification of novel p53 regulatory signalling pathways

  2013cites this paper
• Epigenetic therapy in non-small-cell lung cancer: targeting DNA methyltransferases and histone deacetylases

  2013influential citation
• MDM2, MDMX and p53 in oncogenesis and cancer therapy

  2013cites this paper
• The MDM 2p 53 pathway revisited

  2013cites this paper
• Posttranslational modifications of the retinoblastoma tumor suppressor protein as determinants of function.

  2012cites this paper